title: Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia.
authors.affiliation: Department of Allergy and Clinical Immunology, Duke University, Durham, NC.
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Wright
authors.affiliation: Department of Medicine, Mayo Clinic, Rochester, Minn.
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Butterfield
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Kristin M
authors.initials: KM
authors.lastname: Leiferman
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah. Electronic address: gerald.gleich@hsc.utah.edu.
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Gleich
mesh_terms: D000293:Adolescent; D000328:Adult; D000799:Angioedema / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D002648:Child; D004719:Endomyocardial Fibrosis / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D004801:Eosine Yellowish-(YS) / Q000031:analogs & derivatives*; D004802:Eosinophilia / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D058386:Mitral Valve Annuloplasty; D008945:Mitral Valve Prolapse / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D019284:Thapsigargin / Q000031:analogs & derivatives* / Q000276:immunology; D055815:Young Adult
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; C093013:eosinthapsigargin; D019284:Thapsigargin; D004801:Eosine Yellowish-(YS)